コアギュランス菌の市場規模、シェア、成長分析、タイプ別、供給源別、用途別、エンドユーザー別、地域別 - 産業予測、2025～2032年

コアギュランス菌の世界市場規模は、2023年に9,183万米ドルと評価され、2024年の9,927万米ドルから2032年には1億8,510万米ドルに成長し、予測期間（2025-2032年）のCAGRは8.1％で成長する見通しです。

乳酸菌に似た有益な細菌であるコアギュランス菌の世界市場は、健康意識の高まりと機能性食品需要の急増によって大きな成長を遂げています。治療用途で知られるコアギュランス菌は、IBS、炎症性腸疾患（IBD）、呼吸器感染症などの症状だけでなく、ロタウイルスのような感染症によって引き起こされるものも含め、さまざまなタイプの下痢の治療に効果的です。さらに、免疫系を強化する役割もあり、その他の健康特典もあります。しかし、市場の可能性は、その有効性に関して消費者に広く知られていないことがやや妨げとなっています。とはいえ、新興経済諸国における研究開発の拡大とコアギュランス菌製品への関心の高まりは、将来の成長機会として有望です。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 顧客と購買基準の分析

コアギュランス菌市場規模：タイプ別

• 市場概要
• タイプ1
• タイプ2
• タイプ3

コアギュランス菌市場規模：供給源別

• 市場概要
• 天然資源
• 植物
• 動物
• 臨床情報源
• その他

コアギュランス菌市場規模：用途別

• 市場概要
• 乳製品不使用
• 乳製品
• 穀物
• 薬剤
• 乳児栄養
• その他

コアギュランス菌市場規模：エンドユーザー別

• 市場概要
• 飲食品
• 化粧品産業
• 栄養補助食品メーカー
• 製薬メーカー
• 動物の飼育とケア
• その他

コアギュランス菌市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Kerry Group plc（Ireland）
• Sabinsa Corporation（United States）
• Mitsubishi Chemical Foods Corporation（Japan）
• Sanzyme Biologics（India）
• Unique Biotech Limited（India）
• Syngen Biotech Co., Ltd.（China）
• Synbiotech（Taiwan）
• Ganeden（United States）
• Biosearch Life（Spain）
• ADM Protexin Limited（United Kingdom）
• Bactolac Pharmaceutical, Inc.（United States）
• Nutraceutix, Inc.（United States）
• Thorne Research Inc.（United States）
• Vitamer Labs Inc.（United States）
• Nutralliance Inc.（United States）
• **Microbax（India）
• Zytex Biotech Pvt. Ltd.（India）
• Bioflex（India）
• Fengchen Group Co., Ltd.（China）

結論と推奨事項

Global Bacillus Coagulans Market size was valued at USD 91.83 million in 2023 and is poised to grow from USD 99.27 million in 2024 to USD 185.1 million by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

The global market for Bacillus coagulans, a beneficial bacterium akin to lactobacillus, is witnessing significant growth driven by heightened health awareness and a surge in demand for functional foods. Known for its therapeutic applications, Bacillus coagulans is effective in treating various types of diarrhea, including those caused by infections like rotavirus, as well as conditions such as IBS, inflammatory bowel diseases (IBD), and respiratory infections. Furthermore, its role in bolstering the immune system presents additional health benefits. However, the market's potential is somewhat hindered by widespread consumer unawareness regarding its effectiveness. Nonetheless, the expansion of research and development and increased interest in Bacillus coagulans products in emerging economies presents promising opportunities for future growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bacillus Coagulans market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bacillus Coagulans Market Segmental Analysis

Global Bacillus Coagulans Market is segmented by Type, Sources, Application, End-Users and region. Based on Type, the market is segmented into Type1, Type2 and Type3. Based on Sources, the market is segmented into Natural Source, Plants, Animals, Clinical Sources and Others. Based on Application, the market is segmented into Non-Dairy, Dairy, Cereal, Drugs, Infant Nutrition and Others. Based on End-Users, the market is segmented into Food and Beverages, Cosmeceutical Industries, Nutraceutical Manufacturers, Pharmaceutical Manufacturers, Animal Husbandry and Care and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Bacillus Coagulans Market

The global Bacillus Coagulans market is primarily driven by its significant benefits in addressing acne and various skin conditions, leading to an increased demand within the cosmetics industry. Cosmetic manufacturers are formulating innovative products infused with Bacillus Coagulans, highlighting its anti-aging properties across a wide range of items, including face masks, lotions, scrubs, gels, creams, and cleansers. Additionally, there is a growing trend towards the incorporation of Bacillus Coagulans as a cosmeceutical component in diverse cosmetic products, such as creams and powders. Its effectiveness in managing conditions like atopic dermatitis and eczema further elevates its use in moisturizers and anti-acne treatments, solidifying its role as a crucial ingredient in personal care formulations.

Restraints in the Global Bacillus Coagulans Market

The global Bacillus coagulans market faces certain constraints primarily related to safety concerns and side effects associated with its use. While generally considered safe, indiscriminate dosing can lead to gastrointestinal issues such as gas and bloating. The lack of familiarity with Bacillus coagulans in the human digestive system raises ongoing debates regarding its potential risks and adverse effects. Additionally, some identified strains are not suitable for probiotic applications, and the existing research on these probiotics remains limited. Furthermore, there is apprehension that Bacillus coagulans spores could potentially escape the digestive tract and affect other organs, posing risks for immunocompromised individuals or those with catheters, as this could lead to bacterial infections.

Market Trends of the Global Bacillus Coagulans Market

The Global Bacillus Coagulans market is witnessing significant growth, driven by a rising consumer shift towards health-conscious dietary choices, particularly in dairy-free and vegan segments. This trend is largely fueled by increasing lactose intolerance, milk protein allergies, and a burgeoning vegan population, leading to a heightened demand for non-dairy probiotics. Bacillus coagulans has emerged as a preferred ingredient due to its recognized safety by regulatory bodies like the FDA and EFSA, making its way into functional foods and supplements. Furthermore, its impressive stability during processing enhances its appeal, while affordability positions it as a viable alternative to potentially harmful chemicals in the food industry.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Customer & Buying Criteria Analysis

Global Bacillus Coagulans Market Size by Type & CAGR (2025-2032)

• Market Overview
• Type1
• Type2
• Type3

Global Bacillus Coagulans Market Size by Sources & CAGR (2025-2032)

• Market Overview
• Natural Source
• Plants
• Animals
• Clinical Sources
• Others

Global Bacillus Coagulans Market Size by Application & CAGR (2025-2032)

• Market Overview
• Non-Dairy
• Dairy
• Cereal
• Drugs
• Infant Nutrition
• Others

Global Bacillus Coagulans Market Size by End-Users & CAGR (2025-2032)

• Market Overview
• Food and Beverages
• Cosmeceutical Industries
• Nutraceutical Manufacturers
• Pharmaceutical Manufacturers
• Animal Husbandry and Care
• Others

Global Bacillus Coagulans Market Size & CAGR (2025-2032)

• North America (Type, Sources, Application, End-Users)
  • US
  • Canada
• Europe (Type, Sources, Application, End-Users)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Sources, Application, End-Users)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Sources, Application, End-Users)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Sources, Application, End-Users)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Kerry Group plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sabinsa Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mitsubishi Chemical Foods Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanzyme Biologics (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Unique Biotech Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syngen Biotech Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synbiotech (Taiwan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ganeden (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biosearch Life (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ADM Protexin Limited (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bactolac Pharmaceutical, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nutraceutix, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thorne Research Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vitamer Labs Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nutralliance Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• **Microbax (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zytex Biotech Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioflex (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fengchen Group Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations